Which exercise prescriptions optimize V̇O2max during cancer treatment?—A systematic review and meta‐analysis

The aims of the present systematic review and meta‐analysis were to investigate the effect of exercise on maximal oxygen uptake (V˙O2max) and to investigate whether exercise frequency, intensity, duration, and volume are associated with changes in V˙O2max among adult patients with cancer undergoing...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scandinavian journal of medicine & science in sports 2019-09, Vol.29 (9), p.1274-1287
Hauptverfasser: Bjørke, Ann Christin Helgesen, Sweegers, Maike G., Buffart, Laurien M., Raastad, Truls, Nygren, Peter, Berntsen, Sveinung
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The aims of the present systematic review and meta‐analysis were to investigate the effect of exercise on maximal oxygen uptake (V˙O2max) and to investigate whether exercise frequency, intensity, duration, and volume are associated with changes in V˙O2max among adult patients with cancer undergoing treatment. Medline and Embase through OvidSP were searched to identify randomized controlled trials. Two reviewers extracted data and assessed the risk of bias. The overall effect size and differences in effects for different intensities and frequencies were calculated on change scores and post‐intervention V˙O2max data, and the meta‐regression of exercise duration and volumes was analyzed using the Comprehensive Meta‐Analysis software. Fourteen randomized controlled trials were included in the systematic review, comprising 1332 patients with various cancer types receiving (neo‐)adjuvant chemo‐, radio‐, and/or hormone therapy. Exercise induced beneficial changes in V˙O2max compared to usual care (effect size = 0.46, 95% Confidence Interval = 0.23‐0.69). Longer session duration (P = 0.020), and weekly duration (P = 0.010), larger weekly volume (P 
ISSN:0905-7188
1600-0838
DOI:10.1111/sms.13442